Skip to main content

Table 3 Antigenicity prediction using the Kolaskar and Tongaonkar technique

From: Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients

Start End Peptide Length
223 233 YSLEFQSFGW 10
314 322 YMSLGPMVL 9
812 820 YLVPCYTCL 9
301 310 YYKLVPFWSF 10
962 970 YWQNSRLTF 9
590 598 YSLEFQSFGW 10
148 156 YLVPCYTCL 9
92 101 WWLLPVIVEV 10
448 456 WTAGAAAYY 9
193 201 WLLPVIVEV 9
130 139 SIFGCLLPQK 10